{"name":"TIXiMED, Inc.","slug":"tiximed-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNZjRCMzJ4M043eGdSX21uYS1GQnRzalk5cVlnV1dJWVdGb3h2N2NBOFJYajJHQWZNMEtrM0xIbnNaMXlXNHNaR0ZYWjdEVmZsbU5JbTdtNmJaV3VxUkJtVGRUV3NNRUxlRUFkdkUycGJUc0tvVzVBX3JoTGxBeXphRWtFeHpMMGFOZHhQTXVoMlB1WWsxeXNJaWlFUW1UM1hlWk0wZWpYNjlmZklYVW9fcDRjMnl4Q1pvOUdhcnNDUURiSVVFSDNGak1lRWRIRXRza0RtTExUSkZXQUctb2g2Q0tFRQ?oc=5","date":"2026-03-13","type":"pipeline","source":"Business Wire","summary":"TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust - Business Wire","headline":"TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQeXQtYy1VSGtLUG5aSGdINWN2QmpsdnpDODl1LWc0akhWVHNSQkR2MFk3Xy1fanBYaDllMV93YTA3cEJXRkxZS3lPLTNVS3N3UThvWnBxX2lwYU1URlpuRldlQnV1UUh1OE14NVFwcUs1QkxCMTQyMUF1Tks4eHBodVNpNXhMQ3pQcU1YNG9yX0N4djJKTHN2cUZvR3V3UGsycVNCU1hmcXljemRaYzgxdzd5ZzJsVF9QUE1xWG1QRm9neHI0ZHZSSjRSZlhhQjF5RXd3eFZvanVuY01nOExxN3dKNjc3U1lFUU1PSGljNkVXdjlCbGRpZGtFa1BUSzRQTEp6dmhn?oc=5","date":"2026-03-10","type":"trial","source":"Business Wire","summary":"TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessation in Obesity Model - Business Wire","headline":"TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessation in Obesity Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPYnlYYkRHLXFvRkZFMGZ2WmNid0lQTFdiR0JwU2gxdXpHbGo5Z0FIU0V2MFplbngyZE1FT2VJWkxUSkVYR0FYWm5tdEREbkZtVlNIN1RVWEo1amZlYVpfb2IxcUVUaW50VmszZU1IYXFyYzhMUlUzV2J6LWktUlFzeDBMTmc0U1RyYmIyX3VnaU50R2QwWmw2V3FhUko4aXZxR1h2NWFpZE9rRTl2Z3ZPeGNUUHE4RFEtanNsc0l5UFM2MmJTSGVCby1FenNqQUZvMWVvVmtVbU1mcEpHdU1xT0VhZjNzVV9TX2FWbDNFS3ZmSnljbjNpRThxYTZMQ2p4TzA1aU13?oc=5","date":"2025-05-29","type":"trial","source":"Business Wire","summary":"TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy - Business Wire","headline":"TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNbUNMVUZPR2hYNUo2cWNqWWd5UkdmNDZsX1d5eWdPaUl0ZmpEWTdhYmtRbWZGR2tBRnZWalFhUlJiTDg3NWZpNEUyVjBQNVdZTmFTT0dPQkxodE1sZVM0MF9FSU82MjkwQ01HTkJIQUQ2YUlEMXROckZaQTBEOXJLTFBidDlRekVLcnU1NV90MElYWlB3UVBEbTI2d0xVSmc?oc=5","date":"2024-07-31","type":"regulatory","source":"News-Medical","summary":"FDA clears UAB startup's TIX100 for clinical trials - News-Medical","headline":"FDA clears UAB startup's TIX100 for clinical trials - News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}